Factory Raw Material Top Quality 99% Purity CAS 86386-73-4 Fluconazole

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: White Powder
• Purity: >99%
• Model NO.: Frazer-Fluconazole
• Appearance: White Powder
• CAS No: 86386-73-4
• Shelf Life: 2 Years
• Test Method: HPLC
• MOQ: 1kg
• Storage: Store Cool Dry Place
• Resource: Natural
• Quality Requirement: Strictly Quality Control
• Market: Worldwide
• Service: Welcome to Visit Us
• Melting Point: 138-140°c
• MW: 306.27
• Transport Package: Foil Bag
• Specification: 99%
• Trademark: Xi′an Frazer Biotech Co., Ltd.
• Origin: China
• Production Capacity: 2000kg/Month

Product Description

Factory Raw Material Top Quality 99% Purity CAS 86386-73-4 Fluconazole

Specification

Items	Standard	Results
Appearance	Off-white or white crystal or crystalline powder	White crystalline powder
Melting point	137-141ºC	140ºC
Identification	(1)   (2) should comply with standard (3) should be positive reaction	Complies Complies
Clarity of solution	Should comply with standard	Complies
Assay of fluorin-e	Should be between 11.1-12.4%	12.3%
Involved substance	Should comply with standard	Complies
Assay of chloride	Should comply with standard	Complies
Loss on drying	Not more than 0.5%	0.2%
Residue in ignition	Not more than 0.1%	0.02%
Heavy metals	Not more than 20ppm	Complies
Limit of microbe	Should comply with standard	Complies
Assay	C13H12F2N6O should not less than 98.5% on dry basis	10

What is Fluconazole ?

Fluconazole powder is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. In a bulk powder form, it appears as a white crystalline powder, and it is very slightly soluble in water and soluble in alcohol.

Application

1. Fluconazole is indicated in the treatment of febrile neutropenia when fungal infections are suspected or proven.

2. Fluconazole is indicated in nonimmunocompromised patients for the treatment of onychomycosis caused by tinea unguium, Trichophyton species and Candida species.

3. Fluconazole is indicated for the treatment and suppression of cryptococcal meningitis.

4. Fluconazole is indicated in the treatment of pulmonary and disseminated coccidioidomycosis caused by Coccidioides immitis.

5. Fluconazole is indicated in the treatment of vulvovaginal candidiasis caused by Candida species.

6. Fluconazole is indicated for the treatment of serious infections, including peritonitis, pneumonia, and urinary tract infections, caused by susceptible Candida species.

7. Fluconazole is also indicated for the treatment of systemic infections caused by Candida species in neonates.

8. Fluconazole is indicated for the treatment of esophageal and oropharyngeal candidiasis (thrush) caused by Candida species.

9. Fluconazole is indicated for the prophylaxis of candidiasis in patients undergoing bone marrow transplant who receive cytotoxic chemotherapy and/or radiation therapy.

Product Name	CAS No.	Product Name	CAS No.
Lufenuron	103055-07-8	Toltrazuril	69004-03-1
Nitenpyram	120738-89-8	Praziquantel/Biltricide	55268-74-1
Fenbendazole	43210-67-9	Tetramisole Hcl	5086-74-8
Levamisole	14769-73-4	Ponazuril	9004-4-2
Diclazuril	101831-37-2	Florfenicol	73231-34-2
Ivermectin	70288-86-7	Enrofloxacin Hcl	112732-17-9
Albendazole	54965-21-8	Mebendazole	31431-39-7